Effectiveness of podiatry to prevent foot ulcers in diabetic patients with polyneuropathy

ISRCTN ISRCTN50646165
DOI https://doi.org/10.1186/ISRCTN50646165
Secondary identifying numbers N/A
Submission date
21/04/2010
Registration date
10/06/2010
Last edited
10/06/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Margreet van Putten
Scientific

mgr.Witloxweg 22
Eindhoven
5624JH
Netherlands

Phone +31 (0)62 097 1135
Email m.vanputten01@chello.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effectiveness of preventive podiatric care versus treatment as usual to reduce the number of foot ulcers in diabetic patients with polyneuropathy: a randomised controlled trial
Study acronymPodoproof trial
Study objectivesThe aim of the study was to determine whether preventive podiatric care reduces the number of foot ulcers or results in less severe ulcers in diabetic patients with polyneuropathy and no recent history of foot ulceration or severe foot deformities. Secondary endpoints for the study included markers of ulcer severity such as the number of hospitalisation days for a foot ulcer, the number of surgical or invasive vascular procedures and the number of days until an ulcer was healed.
Ethics approval(s)Ethics board of Academic Hospital Maastricht (azM)/Maastricht University Medical Centre (MUMC) approved on the 15th November 1996 (ref: AZM00230014/151196)
Health condition(s) or problem(s) studiedDiabetic foot
InterventionAfter randomisation, patients in the intervention group made an appointment with a participating local podiatrist within 2 weeks. These podiatrists (n = 20) were alumni of the School for Podiatry in Eindhoven, the Netherlands and were trained additionally for the purpose of this study. Subjects were instructed to visit the podiatrist for examination and treatment of their feet twice a year or more often as needed during the 3 year study period. Podiatric care included removal of callus, trimming nails, application of nail braces, prescribing insoles, orthotic toe devices and other off-loading techniques as well as shoe adjustments. Moreover, education and advice about foot care and shoe wear were given at each visit. Clinical findings and applied therapeutic procedures were recorded.

In the control group extra podiatric consultations in case of (pre-)ulceration were allowed as well as treatment as usual.

Follow-up and care for their diabetes were continued as usual for both intervention and control group patients.
Intervention typeOther
Primary outcome measure1. Development of a foot ulcer during the 3-year follow-up period
2. Number of ulcer related procedures in the 3-month period after the first detection of an ulcer
Secondary outcome measures1. Severity of the ulcer
2. Healing time
3. Major interventions
4. Hospitalisation days related to ulceration

Measured at the onset of ulceration and after 3 month after onset of ulceration.
Overall study start date09/09/1996
Completion date01/05/2002

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants281 patients per study group (562 in total)
Key inclusion criteria1. Patients aged over 18 years, either sex
2. Diabetes mellitus
3. Signs of peripheral polyneuropathy. Polyneuropathy is defined as absence of pressure sensation (10 gram Semmes Weinstein monofilament) and/or absence of the vibration perception sense (128 Hertz tuning fork).
Key exclusion criteria1. Polyneuropathy not related to diabetes
2. Type 1 diabetes with a duration less than 10 years
3. An active foot ulcer or a healed ulcer in the past year
4. Severe peripheral arterial disease (ankle pressure less than 50 mmHg measured with a hand held Doppler)
5. Foot surgery or peripheral bypass surgery during the past year
6. Rheumatoid disease and renal replacement therapy
7. Patients should not have consulted a podiatrist in the past year
Date of first enrolment09/09/1996
Date of final enrolment01/05/2002

Locations

Countries of recruitment

  • Netherlands

Study participating centre

mgr.Witloxweg 22
Eindhoven
5624JH
Netherlands

Sponsor information

University Maastricht (UM) (The Netherlands)
University/education

Division Endocrinology
Department Internal Medicine, MUMC+
PO Box 616
Maastricht
6200MD
Netherlands

Phone +31 (0)43 388 2222
Email m.vanputten01@chello.nl
Website http://www.maastrichtuniversity.nl
ROR logo "ROR" https://ror.org/02jz4aj89

Funders

Funder type

University/education

Dutch Health Insurance Council (College van Zorgverzekeraars [CVZ]) (Netherlands)

No information available

Fontys University of Applied Sciences (Netherlands)

No information available

Maastricht University Medical Centre (Netherlands) - Division of Endocrinology Department of Internal Medicine

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan